Confo Therapeutics
Bruno Ranschaert is an accomplished R&D Application Architect at Confo Therapeutics since March 2021, specializing in the development of connectors and plugins using Java and Kotlin. Previous experience includes roles as an ITS Software Engineer and R&D Software Engineer at Ablynx, where Bruno contributed to the maintenance and enhancement of CLC plugins and the Biorepository application. Additional experience encompasses software engineering positions at NGDATA, De Persgroep, KBC Bank & Verzekering, Atos Worldline, KSZ-BCSS, and Dexia, with a strong focus on application development, software maintenance, and system engineering across various platforms and frameworks. Bruno holds a Master’s degree in Informatics from KU Leuven and a Master’s degree in Econometrics from Vrije Universiteit Brussel.
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.